Challenges for Drug Discovery in a Postgenomic World

Jeffrey Conn, Ph.D.

Professor of Pharmacology and Director of the Vanderbilt Institute for Chemical Biology Program in Drug Discovery, Vanderbilt University School of Medicine

The lecture was part of Vanderbilt Medical's Discovery Lecture Series, featuring the nation's most eminent scientists, speaking on the highest-impact research and policy issues in science and medicine today.